A detailed history of American International Group, Inc. transactions in Nkarta, Inc. stock. As of the latest transaction made, American International Group, Inc. holds 14,901 shares of NKTX stock, worth $78,379. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,901
Previous 15,030 0.86%
Holding current value
$78,379
Previous $99,000 62.63%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$5.59 - $15.71 $721 - $2,026
-129 Reduced 0.86%
14,901 $161,000
Q4 2023

Feb 13, 2024

SELL
$1.31 - $6.6 $79 - $402
-61 Reduced 0.4%
15,030 $99,000
Q3 2023

Nov 13, 2023

BUY
$1.39 - $2.29 $746 - $1,229
537 Added 3.69%
15,091 $20,000
Q2 2023

Aug 04, 2023

SELL
$2.19 - $5.17 $2,752 - $6,498
-1,257 Reduced 7.95%
14,554 $31,000
Q1 2023

May 12, 2023

BUY
$3.37 - $6.3 $1,061 - $1,984
315 Added 2.03%
15,811 $56,000
Q4 2022

Feb 10, 2023

BUY
$5.14 - $14.35 $539 - $1,506
105 Added 0.68%
15,496 $92,000
Q3 2022

Nov 14, 2022

BUY
$12.27 - $18.39 $2,674 - $4,009
218 Added 1.44%
15,391 $203,000
Q2 2022

Aug 12, 2022

BUY
$7.77 - $19.44 $63,465 - $158,785
8,168 Added 116.6%
15,173 $187,000
Q1 2022

May 13, 2022

SELL
$8.66 - $14.99 $4,269 - $7,390
-493 Reduced 6.58%
7,005 $80,000
Q4 2021

Feb 11, 2022

SELL
$12.79 - $26.88 $2,864 - $6,021
-224 Reduced 2.9%
7,498 $115,000
Q3 2021

Nov 12, 2021

SELL
$26.67 - $38.76 $4,880 - $7,093
-183 Reduced 2.31%
7,722 $215,000
Q2 2021

Aug 13, 2021

SELL
$23.94 - $36.68 $94,826 - $145,289
-3,961 Reduced 33.38%
7,905 $251,000
Q1 2021

May 07, 2021

BUY
$31.33 - $59.61 $75,755 - $144,136
2,418 Added 25.59%
11,866 $390,000
Q4 2020

Feb 12, 2021

SELL
$27.03 - $75.62 $7,352 - $20,568
-272 Reduced 2.8%
9,448 $581,000
Q3 2020

Nov 04, 2020

BUY
$23.52 - $47.9 $228,614 - $465,588
9,720 New
9,720 $292,000

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $256M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.